Biohack Blueprint · DoNotAge Intelligence

DoNotAge Scientists & Research Network

A source-linked directory of scientists, investigators, speakers and institutions connected to DoNotAge conferences, grants, trials and research projects. Inclusion describes a verified relationship; it does not imply endorsement.

By Dr. Khaled Mahmoud, MBBChVerified People directory
DoNotAge scientistslongevity researchersDoNotAge Conference speakershealthy ageing researchscientific advisory network
DoNotAge Conference 2026 Watch Conference Highlights

Key points

What this page establishes.

These statements define the scope of the directory and the limits of what its relationships mean.

  • The directory documents specific relationships between scientists and DoNotAge rather than treating conference participation as a blanket endorsement.
  • Each scientist should connect to the exact talk, research project, grant or company role that makes the relationship relevant.
  • Conference speakers, grant recipients, collaborators and advisory-board members are distinct relationship types.

People & institutions

Scientists around the DoNotAge research ecosystem.

Inclusion documents a specific public relationship. It does not imply endorsement, employment or advisory status unless the cited relationship establishes that role.

University of Rochester

Vera Gorbunova, PhD

Doris Johns Cherry Professor; Professor of Biology; Co-director, Rochester Aging Research Center

Speaker at DoNotAge Conference 2026.

Research profile
University of Rochester

Andrei Seluanov, PhD

Dean’s Professor; Professor of Biology; Co-director, Rochester Aging Research Center

Speaker at DoNotAge Conference 2026.

Research profile
Aarhus University

Søren Wilton Kudahl-Laursen

Research Assistant; PhD Student

DoNotAge Conference 2026 speaker. The official conference archive describes an ongoing older-adult muscle-regeneration study comparing DoNotAge Pure Spermidine with placebo; DoNotAge support is listed as research ingredients and matching placebo.

Research profile
Rejuvenation Science Institute

Nicolás Cherñavsky

President

DoNotAge Conference 2026 speaker and lead of an ICR/Unicamp preclinical replication project to which DoNotAge contributed US$25,000. Cherñavsky also co-authored a separate 2025 peer-reviewed acute feasibility/safety study of young-pig-plasma extracellular particles in young rats; that paper is not rejuvenation-efficacy evidence.

Research profile
University of Lincoln

Joanna Ward

PhD Student

DoNotAge Conference 2026 speaker and recipient of a DoNotAge.org-BSRA Small Research Grant. The DoNotAge-BSRA award supports Ward's cardiovascular-inflammation research programme; it is distinct from the funding listed for the registered icosapent-ethyl study, whose protocol names Amarin Global and the University of Lincoln.

Research profile
Texas Tech University

Sergej M. Ostojic, MD, PhD, FACP

Professor of Nutritional Sciences

DoNotAge Scientific Advisory Board member and DoNotAge Conference 2026 speaker. In a DoNotAge video, Ostojic also outlined a planned 24-week older-adult clinical study of the multi-ingredient DoNotAge Performance formulation; the later conference archive described the research as ongoing.

Research profile
Ulster University

Ciara Gallardo Juan

PhD Researcher

DoNotAge Conference 2026 speaker. The official conference archive describes DoNotAge support for her PhD research and reports a human exercise study using DoNotAge Pure Quercetin.

Research profile
USC Leonard Davis School of Gerontology

Constanza Cortes, PhD

Assistant Professor of Gerontology

DoNotAge Conference 2026 speaker. Conference materials report DoNotAge funding for a prospective aged-mouse PS18-versus-exercise study. Cortes' earlier published muscle-to-brain and skeletal-muscle TFEB studies are separate mechanistic research and should not be represented as DoNotAge-funded PS18 efficacy studies.

Research profile
University of Hertfordshire

Lindsay Bottoms, PhD

Professor in Exercise and Health Sciences

DoNotAge Conference 2026 speaker and co-presenter of the conference-reported 20-day Pure Quercetin versus placebo study. The related registered study NCT06230861 lists DoNotAge.org as a collaborator.

Research profile
University of Central Lancashire

Jonathan Sinclair, PhD, DSc

Researcher and clinical-study responsible party

Speaker at DoNotAge Conference 2026; responsible party for ClinicalTrials.gov study NCT06230861, which lists DoNotAge.org as a collaborator.

Relationship source
Durham University

David Weinkove, PhD

Professor

Speaker at DoNotAge Conference 2026.

Relationship source
King's College London

Rebecca Sumner, PhD

Lecturer in Host/Pathogen Interactions

DoNotAge Conference 2026 speaker. No separate DoNotAge-funded Rebecca Sumner research project was independently identified in the reviewed sources as of October 10, 2026.

Research profile
DoNotAge.org

Alan Graves

Founder & Clinical Research Advisor

Founder and Clinical Research Advisor at DoNotAge.org; DoNotAge Conference 2026 speaker discussing the organisation's research-support relationships, including human studies, laboratory research, replication work, PhD projects and provision of research ingredients and matching placebos.

Research profile